UTMD
Utah Medical Products Inc
$67.96
-0.42 (-0.61%)
At close · Jul 10
Market Cap
$216.39M
Shares
3,184,025
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$38.52M
-5.8%
FY2025
Net Income
$11.29M
-18.7%
FY2025
Gross Margin
57.12%
-1.9pp
FY2025
Operating Margin
29.6%
-3.6pp
FY2025
Diluted EPS
$3.48
-12.1%
FY2025
Operating Cash Flow
$14.69M
-0.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $37.53M | $38.52M | $40.9M | $50.22M | $52.28M | $49.05M | $42.18M | $46.9M | $42M | $41.41M | $39.3M | $40.16M | $41.28M | $40.49M | $41.55M | $37.86M | $25.12M | $25.92M | |
| $15.79M | $16.52M | $16.76M | $20.19M | $20.09M | $18.14M | $16.63M | $17.44M | $15.69M | $15.02M | $15.61M | $15.97M | $16.3M | $16.22M | $16.25M | $15.46M | $11.91M | $12.13M | |
| $21.75M | $22M | $24.14M | $30.04M | $32.2M | $30.92M | $25.55M | $29.47M | $26.31M | $26.4M | $23.69M | $24.19M | $24.98M | $24.27M | $25.31M | $22.4M | $13.21M | $13.79M | |
| — | 57.12% | 59.03% | 59.81% | 61.58% | 63.03% | 60.57% | 62.82% | 62.64% | 63.73% | 60.28% | 60.23% | 60.52% | 59.94% | 60.9% | 59.17% | 52.58% | 53.21% | |
| $668K | $668K | $813K | $560K | $493K | $526K | $486K | $483K | $454K | $447K | $475K | $522K | $460K | $491K | $563K | -$518K | $397K | $361K | |
| — | $2.05M | $1.9M | $1.69M | $1.51M | $1.41M | $1.55M | $1.74M | $1.71M | $1.54M | $1.67M | $2.16M | $2.21M | $2.79M | $2.71M | -$2.82M | $1.54M | $1.58M | |
| — | $7.88M | $7.84M | $11.02M | $10.41M | $10.1M | $9.8M | $9.61M | $5.45M | $5.39M | $5.36M | $5.85M | $6.11M | $6.16M | $6.84M | -$7.23M | $2.35M | $2.41M | |
| — | $2.13M | $2.07M | $5.69M | $6.42M | $6.65M | $6.52M | $6.14M | — | — | — | — | — | — | — | — | — | — | |
| $10.81M | $11.4M | $13.59M | $16.78M | $19.79M | $18.88M | $13.71M | $17.63M | $18.7M | $19.01M | $16.19M | $15.65M | $16.2M | $14.83M | $15.2M | $11.84M | $8.92M | $9.43M | |
| — | 29.6% | 33.23% | 33.4% | 37.85% | 38.49% | 32.5% | 37.59% | 44.52% | 45.9% | 41.19% | 38.97% | 39.25% | 36.62% | 36.57% | 31.28% | 35.52% | 36.39% | |
| — | — | — | — | — | — | — | — | — | — | — | $65K | $289K | $438K | $652K | $859K | $25K | $51K | |
| -$208K | -$120K | -$174K | $256K | $188K | $0 | $0 | -$8000 | $437K | -$32K | $132K | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | $0 | $0 | $32K | $0 | $0 | — | $0 | $0 | -$177K | $6000 | $38K | $212K | |
| $3.18M | $14.11M | $16.8M | $20.09M | $20.66M | $19.06M | $13.84M | $17.88M | $19.46M | $19.08M | $16.42M | $15.55M | $15.81M | $14.48M | $14.54M | $11.08M | $9.04M | $9.58M | |
| $578K | $2.82M | $2.93M | $3.45M | $4.19M | $4.27M | $3.04M | $3.16M | $904K | $10.58M | $4.29M | $3.7M | $4.43M | $3.07M | $4.37M | $3.67M | $3.03M | $3.32M | |
| $10.85M | $11.29M | $13.87M | $16.64M | $16.47M | $14.79M | $10.8M | $14.73M | $18.56M | $8.51M | $12.13M | $11.84M | $11.38M | $11.41M | $10.17M | $7.41M | $6.01M | $6.26M | |
| — | 29.3% | 33.92% | 33.12% | 31.51% | 30.15% | 25.6% | 31.4% | 44.18% | 20.54% | 30.86% | 29.49% | 27.56% | 28.17% | 24.47% | 19.58% | 23.94% | 24.15% | |
| $12.12M | $13.78M | $12.63M | $18.02M | $13.49M | $14.02M | $12.3M | $16.23M | $15.61M | $12.41M | $5.84M | $9.12M | $8.13M | $12.27M | $12.22M | $5.78M | $5.73M | $6.34M | |
| USD/shares | — | $3.48 | $3.96 | $4.58 | $4.53 | $4.05 | $2.95 | $3.96 | $4.97 | $2.29 | $3.23 | $3.16 | $3.04 | $3.06 | $2.77 | $2.04 | $1.66 | $1.73 |
| USD/shares | — | $3.48 | $3.96 | $4.57 | $4.52 | $4.04 | $2.94 | $3.94 | $4.95 | $2.28 | $3.22 | $3.14 | $3.02 | $3.02 | $2.74 | $2.03 | $1.65 | $1.72 |
| shares | — | 3.24M | 3.5M | 3.63M | 3.64M | 3.65M | 3.66M | 3.72M | 3.73M | 3.72M | 3.75M | 3.75M | 3.75M | 3.73M | 3.68M | 3.63M | 3.62M | — |
| shares | — | 3.24M | 3.5M | 3.64M | 3.64M | 3.66M | 3.67M | 3.74M | 3.75M | 3.74M | 3.77M | 3.77M | 3.77M | 3.78M | 3.71M | 3.65M | 3.64M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2009–FY2025: $39.4M in buybacks, $73.92M in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Instruments & Supplies median 1.82×
EV/EBIT
—
Medical Instruments & Supplies median 32.36×
P/E (TTM)
20.11×
Medical Instruments & Supplies median 37.77×